Step 1 of 3: describe the case, then continue to structured intake.
Start with the core context, then refine in Intake.
Meds: sertraline 100 mg oral daily, tramadol 50 mg oral q6h PRN pain. Conditions: postoperative pain, hepatic insufficiency. PGx: CYP2D6 poor metabolizer. What do official labels note about interaction risk, reduced analgesic response, and monitoring language?
Meds: capecitabina 1000 mg oral BID, fluorouracilo 500 mg IV semanal. Conditions: enfermedad renal crónica, diabetes. PGx: DPYD metabolizador pobre. ¿Qué indican las fuentes oficiales sobre toxicidad y dosificación?
Meds: 奥美拉唑 20 mg 每日一次, 氯吡格雷 75 mg 每日一次. Conditions: 慢性肾病, 冠状动脉疾病. PGx: CYP2C19 *2/*3。官方说明书如何描述相互作用与抗血小板效果？
Meds: warfarin 5 mg oral daily, amiodarone 200 mg oral daily. Conditions: atrial fibrillation, heart failure. PGx: CYP2C9 *3/*3, VKORC1 -1639 AA. What do official sources note for INR monitoring language?
Meds: tacrolimus 2 mg oral BID, voriconazole 200 mg oral BID. Conditions: post-transplant care, renal insufficiency. PGx: CYP3A5 non-expresser. What do official sources state about interaction magnitude and trough-level monitoring?
Meds: codeine 30 mg oral q6h PRN pain, paroxetine 20 mg oral daily. Conditions: chronic kidney disease, postoperative pain. PGx: CYP2D6 poor metabolizer. What do official sources state about reduced analgesic effect?